generic cialis
JERUSALEM -- Teva Pharmaceutical Industries Ltd.(Nasdaq: TEVA) announced today that the U. S. Food and Drug Administration has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Lilly's osteoporosis treatment Evista[R] (Raloxifene Hydrochloride) Tablets, 60 mg. The brand product had annual sales of approximately $691 million in the United States for the twelve months that ended December 31, 2007, based on IMS sales data. Teva is currently involved in patent litigation concerning this product in the U. S. District Court for the Southern District of Indiana. A trial date has not been set. About Teva Most Popular 5 Regular Mistakes In Public Speaking 10 Jobs That Pay $30 An Hour Public Speaking: 7 Secrets Of Great Public Speakers 13 Job Interview Mistakes To Avoid 3 Questions No Job Seeker Ever Wants To Be Asked? Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. viagra for girls cialis buy generic ed erythromycin +viagra symptoms needed for viagra best good viagra
